Skip to: Curated Story Group 1
Visually Open Nav.
Advertise
with us
US
EUROPE
APAC
CANADA
LATAM
subscribe
Open Search Field.
Home
Topics
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Business Services
Business Services
Business Services
Business Services
Business Services
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Pharmacy Management
Regulatory Services
CXO Insights
Vendor Viewpoint
News
Conferences
Newsletter
Whitepapers
Magazine
CXO Awards
JULY 2022LIFE SCIENCES REVIEW6T he Covid-19 pandemic and the subsequent disruptions have changed the face of the entire human civilization. But there is a silver lining to it everyone has started to take their health (be it mental or physical) seriously. This has contributed to a thriving life sciences sector. And the research powerhouse, Canada, has undoubtedly become the first choice of investors. In the past few years, Canadian biotech and life-sciences ventures have witnessed billions of dollars of investment--just check the number of organizations that have announced venture capital (VC) deals and IPOs from this specific sector! The Federal Budget also has a lot of promises for innovative life sciences and bio-manufacturing firms.Despite all these flourishing trends, Canadian biotech, and life sciences companies are facing a major talent crunch. The reason is the absence of competitive salaries and the changing immigration policies. While every organization is facing challenges, startups are the hardest hits. The situation necessitates businesses to create sound employee recruitment and retention metrics. This will help not just in bringing the best talents but in retaining them to sustain innovation.Needless to say, these challenges won't be solved in a single day. It will take time and lots of effort. Until this happens, the biotech and life sciences startups need to rightly utilize the investments to embark on the journey of innovation and put their best foot forward. Fortunately, startups realize this, and they are bringing several breakthrough ideas to the table. In this edition, our aim is to introduce readers to some of the innovative biotech startups of Canada that have traversed beyond all the adversaries to bring their ideas and solutions to the world.Let us know your thoughts.EDITORIALA Glimpse into the Canadian Biotech Startup LandscapeCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com July - 25 -2022, Vol 03, Issue - 14 Published by ValleyMedia, Inc. (ISSN 2831-8331)To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersGiftson JoshuaJoe Philip Shirley FaithRussell ThomasVisualizersAsher BlakeDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.com
<
Page 5
|
Page 7
>